secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001493152-25-008275
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack appoints diabetes expert Dr. Guillermo Umpierrez to Medical Advisory Board
--------------------------------------------------------------------------------

- Dr. Umpierrez, Professor of Medicine at Emory and past ADA president for Medicine & Science, joins effective immediately.
- He will provide strategic guidance as Glucotrack advances its long-term implantable CBGM system through clinical development.
- Glucotrack's CBGM has 3-year sensor life, no wearable component, and measures blood glucose directly to reduce lag time.
- CEO Paul Goode cites Dr. Umpierrez's clinical and research expertise as valuable for upcoming human trials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225008275/0001493152-25-008275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225008275/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer